<DOC>
	<DOCNO>NCT02453334</DOCNO>
	<brief_summary>Phase III , multicenter , randomize , double-blinded , prospective study two parallel treatment group . Patients present hematologist/oncologist satisfy inclusion exclusion criterion eligible participation 18-week study .</brief_summary>
	<brief_title>Can Iron Lessen Anemia Due Cancer Chemotherapy : A Study Investigate Efficacy Safety Injectafer®</brief_title>
	<detailed_description>This Phase III , multicenter , randomize , double-blinded , prospective study two parallel treatment group . Patients present hematologist/oncologist satisfy inclusion exclusion criterion eligible participation 18-week study . Subjects meet inclusion criterion exclusion criterion , randomize trial ( Group A B ) .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Subjects ( male female ) ≥ 18 year age able give inform consent study . Subjects nonmyeloid malignancy Receiving chemotherapy part cancer treatment least 4 week treatment remain . Screening visit central laboratory hemoglobin ( Hgb ) ≤11 g/dL , ≥8 g/dL . Ferritin 100 800 ng/mL transferrin saturation ( TSAT ) = &lt; 35 % Subjects must Eastern Coopertative Oncology Group ( ECOG ) performance status 02 . Life expectancy least 6 month . Demonstrate ability understand requirement study , willingness abide study restriction return required assessment . Previous participation ferric carboxymaltose clinical trial . Known hypersensitivity reaction component ferric carboxymaltose . Subjects overt bleed Any anemia treatment within 4 week inclusion ( oral iron , IV iron , transfusion , erythropoiesisstimulating agent ) . Subjects erythropoiesisstimulating agent . Requiring dialysis treatment chronic kidney disease . Any nonviral infection . Known positive hepatitis evidence active disease . Received investigational drug within 30 day screen . Alcohol drug abuse within past 6 month . Hemochromatosis iron storage disorder . Any laboratory abnormality , medical condition psychiatric disorder opinion Investigator would put subject 's disease management risk may result subject unable comply study requirement . Pregnant actively try become pregnant ( Female subject childbearing age must negative pregnancy test screen practice acceptable method birth control study ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>